BIOTU
Biotech Acquisition Company [BIOTU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BIOTU Stock Summary
In the News
BIOTU Financial details
Company Rating
-
Market Cap
0
Income
13.24M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0.01
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
0.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.11
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-86.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
10%
ROE
23%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.73-11.1146
52W High
-7.82%
52W Low
+26.75%
RSI
-
Rel Volume
1.68
Avg Volume
797
Volume
1.34K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-7.65%
-
-
-
-
Beta
-
-
-
Volatility
0.36%, 0.36%
Prev Close
0%
Price
10.14
Change
-0.2%
Company Profile
- Volume Average 797
- CEO Dr. Michael Shleifer Ph.D.
- Headquarters New York,NY,US
- IPO Date 2021-01-22
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
